Home > PJ (current issue) > News / Daily News | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7315 p303-307
4 September 2004

This section
Reprint   Photocopy

PDF 245K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

303 One month wait for full details of contract in England Community pharmacists in England will have to wait another month to find out exactly how they will fare financially under the new contract. ...more

303 NHS IT plans to be investigated by National Audit Office The National Audit Office (NAO), is to investigate whether the English National Programme for IT (NPfIT) will be value for money for the NHS ...more

304 Resistance to influenza drug higher than expected Resistance to the antiviral drug oseltamivir may be higher than expected, new research shows ...more

304 New data from 4S trial show statins safe in long term Reassuring data have been published on the long-term safety of statins ...more

304 Reassurance over long-term safety of calcium antagonists Long-acting nifedipine is safe for use by patients with stable angina ...more

304 Gel helps stress incontinence A gel that is injected into the urethra reduces leakage in women suffering from stress urinary incontinence ...more

304 Wear elastic stockings after DVT Patients with deep venous thrombosis can reduce their risk of post-thrombotic syndrome by wearing compression stockings ...more

304 Risks of sugary drinks clarified Strategies to prevent obesity should focus on reducing consumption of sugary drinks ...more

305 Nine risk factors that will predict most heart attacks Nine easily measured risk factors can predict more than 90 per cent of heart attacks, according to a major global study ...more

305 Kidney protection in diabetes comparable for angiotensin receptor blocker and ACE inhibitor Telmisartan, the angiotensin receptor blocker (ARB), is comparable to the angiotensin converting enzyme (ACE) inhibitor enalapril in protecting against deterioration in kidney function in patients with type 2 diabetes ...more

305 New cannabinoid receptor blocker found effective in obesity Treating obesity with the selective cannabinoid-1 receptor blocker rimonabant is significantly more effective than reducing calorie intake alone ...more

305 Can early, aggressive statin use cut cardiovascular events? It remains unclear whether aggressive use of statins to lower cholesterol after an acute coronary syndrome (ACS) event may prevent death and major cardiovascular events, following inconclusive results from a new trial ...more

306 NICE changes tune on eczema drugs Topical tacrolimus and pimecrolimus have both been approved by the National Institute for Clinical Excellence for use in atopic eczema ...more

306 Use topical steroids only once or twice a day Topical steroids should be used only once or twice a day in the treatment of atopic eczema ...more

306 Asthma prevalence is stable The rate of increase of the prevalence of asthma in children appears to have slowed, according to UK data published last week ...more

306 New vaccines information Leaflets explaining changes to the childhood immunisation programme in Scotland will be sent to pharmacies this week ...more

306 NPSA hand cleaning alert All hospital patients are to have an alcohol-based hand rub placed by their bedsides to encourage health care staff to clean their hands ...more

307 Pharmacists can accelerate hospital discharge Hospital pharmacy staff can contribute to the timely discharge of patients from hospital by making sure that discharge medicines are ready on time ...more

307 Drug-related deaths down ...more

307 Diabetes educational resource ...more

307 Probiotics not effective in vaginal thrush Lactobacillus is not effective in preventing vulvovaginal candidiasis after antibiotic treatment, a new Australian study has shown.
...more

307 NHS overseas recruitment to be tightened up Proposals to tighten up the National Health Service code of practice on recruitment of staff from overseas have been announced ...more

Back to Top


©The Pharmaceutical Journal